ALK-IN-29 (compound 4c) exhibits inhibitory effects on tyrosine protein kinases such as ALK, CDK2/CyclinE1, and FAK, with the strongest inhibition observed against ALK kinase, displaying a 40.63% inhibition rate at a concentration of 10 µM. ALK-IN-29 is applicable in cancer research.
Molecular Weight:
457.58
Formula:
C29H32FN3O
Target:
CDK|||FAK
* VAT and and shipping costs not included. Errors and price changes excepted
